On March 13, 2026, 60 Degrees Pharmaceuticals, Inc. filed an updated legal opinion regarding its at-the-market equity offering program. The opinion confirms the validity of shares to be sold under the program, ensuring compliance with applicable laws. This filing does not alter the terms of the ATM Program but provides necessary legal assurance for future transactions.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.